AxoGen (NASDAQ:AXGN) Downgraded to “Hold” at StockNews.com

StockNews.com downgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a report published on Wednesday. A number of other brokerages also recently issued reports on AXGN. Cantor Fitzgerald reiterated an overweight rating and set a $16.00 price objective on shares of AxoGen in a research note on […]

Leave a Reply

Your email address will not be published.

Previous post Datadog (NASDAQ:DDOG) Price Target Raised to $110.00 at Morgan Stanley
Next post The Goldman Sachs Group Downgrades Imperial Oil (TSE:IMO) to Neutral